It’s 2022 and we’re still battling COVID. Let’s introduce CBD to make the conversation a little more tolerable.

Thankfully, there’s some research happening around CBD and COVID. A recent study found: Compounds in cannabis can prevent infection from the virus that causes Covid-19.*

Buuut, it’s a bit too early to make that claim official.

Here’s a bit more about what that study says:

“The researchers found that two cannabinoid acids commonly found in hemp varietals of cannabis, CBGA and CBDA, can bind to the spike protein of SARS-CoV-2, the virus that causes Covid-19.

By binding to the spike protein, the compounds can prevent the virus from entering cells and causing infection, potentially offering new avenues to prevent and treat the disease.”

Before confirmation is warranted, human trials are in order. Those can take years and a lot of money. Add COVID to that, and then, we’re talking about marijuana, which is not legal at the federal level, yet. To them, it’s still a Schedule I drug, with “no accepted medical value.” Hmmm, but cannabinoids are FDA-approved to treat epilepsy and nausea from chemotherapy. This is a little bonkers. Welcome to the world of cannabis research.

We hope more comprehensive studies take place for CBD in all of its capacities. We’re hopeful they will. Because we know CBD offers muscle and joint pain relief, reduced anxiety, improved sleep, clearing acne and eczema, anti-seizure, digestion, allergies, and on and on.

It will be a while before the FDA approves claims that CBD can prevent COVID. In the meantime, it definitely helps with the stress of the situation!

*(Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants,” was published by the Journal of Natural Products. 2022)

Back to blog